• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用

The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.

作者信息

Ozturk Sari Sule, Taskin Orhun Cig, Gundogdu Gokcen, Yegen Gulcin, Onder Semen, Keskin Metin, Saglam Sezer, Ozluk Yasemin, Gulluoglu Mine, Mete Ozgur

机构信息

Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

出版信息

Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.

DOI:10.1007/s12022-016-9424-9
PMID:26936845
Abstract

This study investigated the impact of phosphohistone-H3 (PHH3)-assisted mitotic count by comparing its performance with conventional mitotic count and Ki67 score as well as the status of distant metastasis. A total of 43 surgically resected pancreatic neuroendocrine tumors (panNET) with complete follow-up information has been subjected to a standardized assessment with respect to mitotic count (both conventional and PHH3-assisted) and Ki67 score. Five participants assessed mitotic count and the time spent was recorded in both methods. All tumors were assigned to a G1 category of mitotic rate on conventional mitotic count that failed to identify three tumors with a G2 category of mitotic rate on PHH3. Near-perfect and fair agreements were achieved among observers when using PHH3 and conventional method, respectively. The mean time spent to determine mitotic count on PHH3-stained slides was significantly shorter (p < 0.001). The performance of PHH3-assisted mitotic grade category was significant as the three cases with a G2 mitotic category were associated with distant metastasis (p = 0.01). Despite its performance, the PHH3-assisted mitotic count downgraded 17 cases that were classified as G2 based on Ki67 scores in this series. The Ki67 grade category was either the same or higher than the mitotic grade category. Ten patients developed distant metastasis. Eleven tumors exhibited vascular invasion characterized by intravascular tumor cells admixed with thrombus. Our results indicate that PHH3-assisted mitotic count facilitates an accurate mitotic count with a perfect agreement among observers. The small size of this cohort is an important limitation of the current study, a G2 mitotic grade category based on PHH3 immunohistochemistry was one of the correlates of panNETs with distant metastasis. While the prognostic impact of PHH3-assisted mitotic count needs to be clarified in larger cohorts, Ki67 scores designated higher grade category in all cases; thus, it was the best determinant of the tumor grade. More importantly, the presence of vascular invasion along with the Ki67 grade category was found to be independent predictors of distant metastasis.

摘要

本研究通过将磷酸化组蛋白-H3(PHH3)辅助的有丝分裂计数与传统有丝分裂计数、Ki67评分以及远处转移状态进行比较,调查了其影响。共有43例接受手术切除且有完整随访信息的胰腺神经内分泌肿瘤(panNET)接受了关于有丝分裂计数(传统和PHH3辅助)和Ki67评分的标准化评估。5名参与者评估有丝分裂计数,并记录两种方法所花费的时间。所有肿瘤在传统有丝分裂计数中被归类为有丝分裂率G1级,但其中3例在PHH3检测中为有丝分裂率G2级。使用PHH3和传统方法时,观察者之间分别达成了近乎完美和一般的一致性。在PHH3染色切片上确定有丝分裂计数所花费的平均时间显著更短(p < 0.001)。PHH3辅助的有丝分裂分级类别的表现具有显著性,因为3例有丝分裂类别为G2级的病例与远处转移相关(p = 0.01)。尽管有其表现,但在本系列中,PHH3辅助的有丝分裂计数将17例基于Ki67评分被归类为G2级的病例降级。Ki67分级类别与有丝分裂分级类别相同或更高。10例患者发生远处转移。11个肿瘤表现出血管侵犯,其特征为血管内肿瘤细胞与血栓混合。我们的结果表明,PHH3辅助的有丝分裂计数有助于准确计数有丝分裂,观察者之间达成了完美的一致性。本队列规模较小是当前研究的一个重要局限,基于PHH3免疫组化的有丝分裂G2级类别是panNETs与远处转移的相关因素之一。虽然PHH3辅助的有丝分裂计数的预后影响需要在更大的队列中阐明,但在所有病例中Ki67评分指定了更高的分级类别;因此,它是肿瘤分级的最佳决定因素。更重要的是,发现血管侵犯的存在以及Ki67分级类别是远处转移的独立预测因素。

相似文献

1
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.
2
Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.磷酸组蛋白 H3 免疫组化染色的有丝分裂计数可预测生存并提高胰腺高分化神经内分泌肿瘤的观察者间可重复性。
Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.
3
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
4
The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.通过数字图像分析测定的磷酸化组蛋白H3有丝分裂指数在细针穿刺细胞学标本中胰腺内分泌肿瘤评估中的潜在价值。
Acta Cytol. 2013;57(3):291-5. doi: 10.1159/000350885. Epub 2013 Apr 25.
5
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.Ki67 增殖指数和有丝分裂率的纳入可提高分化良好的胰腺神经内分泌肿瘤的分级。
Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.
6
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3(PHH3)是预测胰腺神经内分泌肿瘤预后的一种更优的增殖标志物。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):609-617. doi: 10.1245/s10434-016-5171-x. Epub 2016 Mar 28.
7
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.利用 Ki-67 增殖指数、磷酸化组蛋白 H3(PHH3)和 BCL-2 提高细针抽吸术对胰腺神经内分泌肿瘤肿瘤生物学侵袭性的预测能力。
Ann Diagn Pathol. 2023 Aug;65:152149. doi: 10.1016/j.anndiagpath.2023.152149. Epub 2023 Apr 21.
8
Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.胰腺神经内分泌肿瘤的分级与预后评估:Ki67与PHH3的比较研究
J Histochem Cytochem. 2017 Jul;65(7):399-405. doi: 10.1369/0022155417708186. Epub 2017 May 22.
9
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.磷酸组蛋白 H3(PHH3)作为脑膜瘤分级中有丝分裂像计数的替代物:PHH3(S10)与 PHH3(S28)抗体的比较。
Virchows Arch. 2019 Jan;474(1):87-96. doi: 10.1007/s00428-018-2458-2. Epub 2018 Sep 29.
10
Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.看得更仔细才能更好地达成一致:磷酸化组蛋白H3提高了脑膜瘤分级中有丝分裂计数的观察者间一致性,并设定了新的特定阈值。
Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.

引用本文的文献

1
Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low-Grade Neoplasms: A Case with a Highly Increased Proliferation Rate.胰腺神经内分泌微瘤(2022年世界卫生组织分类)并非总是低级别肿瘤:一例增殖率显著升高的病例
Endocr Pathol. 2024 Jun;35(2):147-153. doi: 10.1007/s12022-024-09802-7. Epub 2024 Feb 26.
2
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.利用磷酸化组蛋白 H3(PHH3)抗体与苏木精和伊红复染,提高有丝分裂细胞计数的准确性和效率,作为乳腺癌分级的一部分。
Histopathology. 2023 Feb;82(3):393-406. doi: 10.1111/his.14837. Epub 2022 Nov 18.
3

本文引用的文献

1
An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.肾上腺皮质癌的国际Ki67重复性研究。
Am J Surg Pathol. 2016 Apr;40(4):569-76. doi: 10.1097/PAS.0000000000000574.
2
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
3
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.
Quantitative Assessment of Epithelial Proliferation in Rat Mammary Gland Using Artificial Intelligence Independent of Choice of Proliferation Marker.
使用人工智能对大鼠乳腺上皮细胞增殖进行定量评估,与增殖标志物的选择无关。
J Histochem Cytochem. 2022 Mar;70(3):237-250. doi: 10.1369/00221554221075327. Epub 2022 Jan 20.
4
Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis.重新审视胰腺神经内分泌肿瘤的临床病理预后因素以更好地确定不良预后
Endocr Pathol. 2021 Dec;32(4):461-472. doi: 10.1007/s12022-021-09687-w. Epub 2021 Jul 20.
5
CUX1-Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors.CUX1——胰腺神经内分泌肿瘤肿瘤进展的转录主调控因子
Cancers (Basel). 2020 Jul 19;12(7):1957. doi: 10.3390/cancers12071957.
6
Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication.胰腺神经内分泌肿瘤:关于术语、分类和预后的现状及持续争议
J Gastrointest Oncol. 2020 Jun;11(3):548-558. doi: 10.21037/jgo.2020.03.07.
7
Clinical and histopathological predictors of outcome in malignant meningioma.恶性脑膜瘤的临床和组织病理学预后预测因素。
Neurosurg Rev. 2020 Apr;43(2):643-653. doi: 10.1007/s10143-019-01093-5. Epub 2019 Mar 13.
8
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.磷酸组蛋白 H3(PHH3)作为脑膜瘤分级中有丝分裂像计数的替代物:PHH3(S10)与 PHH3(S28)抗体的比较。
Virchows Arch. 2019 Jan;474(1):87-96. doi: 10.1007/s00428-018-2458-2. Epub 2018 Sep 29.
9
Tumor Digital Masking Allows Precise Patient Triaging: A Study Based on Ki-67 Scoring in Gastrointestinal Stromal Tumors.肿瘤数字掩码可实现精确的患者分类:一项基于胃肠道间质瘤中Ki-67评分的研究。
Scanning. 2018 Sep 2;2018:7807416. doi: 10.1155/2018/7807416. eCollection 2018.
10
Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.胃肠道、胰腺、肺和胸腺神经内分泌肿瘤的免疫组织化学生物标志物。
Endocr Pathol. 2018 Jun;29(2):150-168. doi: 10.1007/s12022-018-9522-y.
胰腺神经内分泌肿瘤中Ki67指数的计算:四种计数方法的比较分析。
Mod Pathol. 2015 May;28(5):686-94. doi: 10.1038/modpathol.2014.156. Epub 2014 Nov 21.
4
Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.磷酸组蛋白 H3 免疫组化染色的有丝分裂计数可预测生存并提高胰腺高分化神经内分泌肿瘤的观察者间可重复性。
Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.
5
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.苏木精-伊红和磷酸化组蛋白 H3 有丝分裂计数及 Ki-67 指数在肾上腺皮质癌中的比较诊断和预后性能。
Mod Pathol. 2014 Sep;27(9):1246-54. doi: 10.1038/modpathol.2013.230. Epub 2014 Jan 17.
6
Neuroendocrine tumors of the pancreas: current concepts and controversies.胰腺神经内分泌肿瘤:当前概念与争议
Endocr Pathol. 2014 Mar;25(1):65-79. doi: 10.1007/s12022-013-9295-2.
7
Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues.胃肠胰神经内分泌肿瘤:历史背景与当前问题。
Semin Diagn Pathol. 2013 Aug;30(3):186-96. doi: 10.1053/j.semdp.2013.06.005.
8
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.Ki67 增殖指数和有丝分裂率的纳入可提高分化良好的胰腺神经内分泌肿瘤的分级。
Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.
9
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).胰腺神经内分泌肿瘤的预后因素和长期结果:Ki-67 指数对生存的影响大于疾病分期。西班牙国家肿瘤登记处(RGETNE)的丰富经验。
Neuroendocrinology. 2013;98(2):156-68. doi: 10.1159/000355152. Epub 2013 Sep 19.
10
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.单中心 26 年非功能性胰腺神经内分泌肿瘤经验:对现行分期系统的验证和新的预后列线图。
Ann Surg. 2014 Feb;259(2):204-12. doi: 10.1097/SLA.0b013e31828f3174.